Central nervous system infections following esophageal dilation in children.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology* / Q000517:prevention & control; D002057:Burns, Chemical / Q000628:therapy*; D002493:Central Nervous System Diseases / Q000209:etiology* / Q000517:prevention & control; D002675:Child, Preschool; D004106:Dilatation; D004947:Esophagus / Q000293:injuries*; D006801:Humans; D008297:Male; D011292:Premedication
D000900:Anti-Bacterial Agents